vasoactive intestinal peptide receptors
Vasoactive Intestinal Peptide (VIP) and VIP Receptors Elucidation of Structure and Function for Therapeutic Applications
... The distribution of VPAC1 and VPAC2 has been ex- tensively analyzed. VPAC1 is expressed in the liver, lungs, kidneys, prostate gland, mammary glands, spleen, lymphocytes, mucosa of the stomach and small intestine, and ...
9
Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro
... VIP/PACAP receptors, the so- called VPAC1 and VPAC2 molecular species (using the International Union of Pharmacology nomen- clature), which were extensively characterized, in terms of sequence, pharmacological ...
12
Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats
... The VIP neuropeptide is unable to cross the BBB and undergoes a rapid degradation in blood in vivo. Therefore, the nasal route for administration was investigated for its brain delivery. Preliminary ex- periments were ...
11
Actin reorganization is involved in vasoactive intestinal peptide induced human mast cells priming to fraktalkine-induced chemotaxis
... The crosstalk between different agonist stimulants of cell receptors may indicate a novel role for F-actin physical reorganization independent from shape changes and increase in its contents in mast cells ...
6
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension
... the vasoactive intestinal peptide (VIP) shows striking pharmacological characteristics that might be worthy of testing for its ability in combating ...VIP receptors (VPAC-1 and VPAC-2) ...
9
Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse
... Vasoactive intestinal peptide (VIP) has potent growth-related actions that influence cell mitosis, neuronal survival, and neurodifferentiation in cell ...VIP receptors, which were restricted ...
9
Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent
... Vasoactive intestinal peptide (VIP) has been shown to regulate early postimplantation growth in rodents through central nervous system ...VIP receptors in the central nervous ...
8
Localization and function of VIP and PACAP in the heart
... Vasoactive intestinal peptide (VIP) is a linear 28-amino-acid peptide with molecular weight of 3,326 Da that is generated by enzymatic cleavage from its precursor molecule, ...of ...
6
Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain
... tide, is a central nervous system (CNS) neurotransmitter and neuromodulator with neurotrophic properties, including stim- ulation of astrocytic mitoses (18), increase of neuronal survival (19–21), and promotion of early ...
9
Role of vasoactive intestinal peptide in osteoarthritis
... 3 receptors: VIP receptor type 1 (VPAC1), VIP receptor type 2 (VPAC2) and pituitary ad- enylate cyclase-activating polypeptide (PACAP) type 1 (PAC1) receptor [20, ...These receptors belong to fam- ily 2 of ...
6
The action of vasoactive intestinal peptide antagonists on peptidergic modulation of the squid Schwann cell
... The effects of two specific antagonists of vasoactive intestinal peptide VIP receptors were investigated on the VIP-induced hyperpolarization of the membrane potential of the Schwann cel[r] ...
12
Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review
... VIP receptors were found on submucosal glands, epithelial cells, and arterial but not sinusoidal vessels ...VIP receptors are also expressed in innate immune cell types, including human mast cells, ...
8
Vasoactive intestinal peptide stabilizes intestinal immune homeostasis through maintaining interleukin-10 expression in regulatory B cells
... patients with a food allergy had a Th2 response in the peripheral system, and the clinical symptoms of UC can be ameliorated by food allergen-specific immunotherapy [23], suggesting that food allergen-related immune ...
12
PACAP and its receptors in cranial arteries and mast cells
... activating peptide (PACAP), which exists in the body as 38- and 27- amino acid pep- tides [4, ...share receptors with their family member vasoactive intestinal peptide (VIP) ...
11
Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens
... production of endogenous VIP mRNA in the LGBd. VIP, as a neurotransmitter in the central system [16, 17], is widely distributed in neurons [18] and binds to receptors VPAC1, VPAC2, and PAC1 [19]. After binding to ...
9
Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain
... GLUT1 receptors and important rate of metabolic activity in these cortical areas could be responsible of the high VIP uptake observed in the an- terior and posterior parts of the brain (Dobrogowska and Vorbrodt, ...
9
Abstract
... results in the suppression of small−intestinal and gallbladder motility and determines the periodic appearance of the migrating motor complex, while diversion of bile from the duodenum causes the opposite effect ...
7
VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage
... their receptors have been proposed as potential candidates for the treatment of inflammatory and autoimmune conditions such as ...in peptide and receptor KO mice have brought new infor- mation regarding the ...
14
Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
... This is the first study to provide a thorough investiga- tion of the CD4 + T cell profile in CFS/ME patients through the assessment of cytokine secretion and regu- latory protein levels in particular VPACR2 ...
9
Transcriptional modulation by VIP: a rational target against inflammatory disease
... these receptors was then changed to VPAC1 (VIP1) and VPAC2 (VIP2; Harmar et ...protein receptors and both receptors have now been identified in a wide range of tissues in different animal phyla ...
10